Page last updated: 2024-08-17

medroxyprogesterone acetate and Hirsutism

medroxyprogesterone acetate has been researched along with Hirsutism in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19903 (20.00)18.7374
1990's8 (53.33)18.2507
2000's2 (13.33)29.6817
2010's2 (13.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, SS; Chung, JP; Chung, TK; Yiu, AK1
Berenson, AB; Breitkopf, CR; Odom, SD; Rahman, M1
Kanasaki, H; Miyazaki, K; Oride, A; Purwana, IN1
Huber, H; Schmidt, JB; Spona, J1
Carpenter, PC; Turk, DM1
Faure, N; Lemay, A1
Simberg, N; Stenman, UH; Tiitinen, A; Ylikorkala, O1
Abdul-Malak, ME; Morcos, RN; Shikora, E1
Carmina, E; Janni, A; Lobo, RA1
Silfvast, A; Simberg, N; Tiitinen, A; Viinikka, L; Ylikorkala, O1
Cunningham, SK; Fiad, TM; McKenna, TJ1
Carmina, E; Lobo, RA1
Bahçeci, M; Bayhan, G; Demirkol, T; Erden, AC; Ertem, M; Yalinkaya, A1
Schmidt, JB1
Huber, J; Schmidt, JB; Spona, J1

Trials

7 trial(s) available for medroxyprogesterone acetate and Hirsutism

ArticleYear
A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
    Journal of pediatric and adolescent gynecology, 2014, Volume: 27, Issue:3

    Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cross-Over Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Severity of Illness Index; Testosterone; Young Adult

2014
Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 79, Issue:2

    Topics: Adolescent; Adult; Androgens; Androstenedione; Drug Synergism; Estradiol; Female; Goserelin; Hirsutism; Humans; Medroxyprogesterone Acetate; Sex Hormone-Binding Globulin; Testosterone

1994
Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy.
    Fertility and sterility, 1994, Volume: 61, Issue:3

    Topics: Adolescent; Adult; Estrogen Replacement Therapy; Female; Hair; Hirsutism; Humans; Leuprolide; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Testosterone

1994
Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism.
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 78, Issue:1

    Topics: Adolescent; Adult; Androgens; Drug Synergism; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Hirsutism; Humans; Medroxyprogesterone Acetate; Menstruation; Triptorelin Pamoate

1994
High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:2

    Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Goserelin; Hirsutism; Humans; Hydroxyproline; Hyperandrogenism; Medroxyprogesterone Acetate; Testosterone

1996
Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.
    Human reproduction (Oxford, England), 1997, Volume: 12, Issue:4

    Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Medroxyprogesterone Acetate; Receptors, LHRH; Remission Induction; Triptorelin Pamoate

1997
A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
    Clinical and experimental obstetrics & gynecology, 2000, Volume: 27, Issue:3-4

    Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Androstenedione; Animals; Dehydroepiandrosterone Sulfate; Delayed-Action Preparations; Enzyme Inhibitors; Estrogens, Conjugated (USP); Female; Finasteride; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Horses; Humans; Leuprolide; Luteinizing Hormone; Medroxyprogesterone Acetate; Testosterone

2000

Other Studies

8 other study(ies) available for medroxyprogesterone acetate and Hirsutism

ArticleYear
Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills.
    American journal of obstetrics and gynecology, 2008, Volume: 199, Issue:4

    Topics: Acne Vulgaris; Adolescent; Adult; Affect; Bone Density; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Emotions; Female; Hirsutism; Humans; Medroxyprogesterone Acetate; Odds Ratio; Weight Gain

2008
Successful pregnancy after the treatment of primary amenorrhea in a patient with non-classical congenital adrenal hyperplasia.
    The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:1

    Topics: Adrenal Hyperplasia, Congenital; Adult; Amenorrhea; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hirsutism; Humans; Hydrocortisone; Infant, Newborn; Medroxyprogesterone Acetate; Ovulation Induction; Pregnancy; Pregnancy Outcome; Treatment Outcome

2013
[Therapeutic possibilities in hirsutism].
    Gynakologische Rundschau, 1984, Volume: 24, Issue:3

    Topics: Androgens; Bromocriptine; Dexamethasone; Female; Hirsutism; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate

1984
Hirsutism.
    Current therapy in endocrinology and metabolism, 1994, Volume: 5

    Topics: Androgen Antagonists; Bromocriptine; Contraceptives, Oral, Combined; Dexamethasone; Female; Finasteride; Goserelin; Hirsutism; Humans; Ketoconazole; Leuprolide; Medroxyprogesterone Acetate; Nafarelin

1994
Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 79, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Androstenedione; Drug Implants; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Medroxyprogesterone Acetate; Pilot Projects; Polycystic Ovary Syndrome; Progesterone; Testosterone; Uterine Hemorrhage

1994
Role of progesterone deficiency in the development of luteinizing hormone and androgen abnormalities in polycystic ovary syndrome.
    European journal of endocrinology, 1996, Volume: 135, Issue:3

    Topics: Androgens; Cohort Studies; Female; Gonadotropins; Hirsutism; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Progesterone; Progesterone Congeners; Prospective Studies; Reference Values

1996
[The concept of the causal therapy of hirsutism].
    Zeitschrift fur Hautkrankheiten, 1986, Feb-15, Volume: 61, Issue:4

    Topics: Cimetidine; Cyproterone; Cyproterone Acetate; Hirsutism; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Androgen; Spironolactone

1986
Medroxyprogesterone acetate therapy in hirsutism.
    The British journal of dermatology, 1985, Volume: 113, Issue:2

    Topics: Administration, Topical; Adult; Androgens; Female; Hair; Hirsutism; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects

1985